Hypertension intracrânienne et lupus
Élisabeth Maillart(Sorbonne Université), Olivier Gout(Université Jean Moulin Lyon III), Mickaël Alexandre Obadia(Fondation Ophtalmologique Adolphe de Rothschild), Antoine Guéguen(Fondation Ophtalmologique Adolphe de Rothschild), Catherine Vignal(Fondation Ophtalmologique Adolphe de Rothschild), Antoine Moulignier(Institut Pasteur)
Cited by 2
Related Papers
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
|The Lancet Neurology|2019|185
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
|Multiple Sclerosis and Related Disorders|2020|179
Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?
|Journal of Neuroradiology|2020|95
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
|Neurology Neuroimmunology & Neuroinflammation|2017|67